These data might suggest that protein levels of c-MYC, although different between the three prostate cancer cell lines, are sufficient to promote ABCC1 expression and activation of the ABCC1/LPI pathway to a similar extent in these cells. The gene discussed is ABCC1; the disease is prostate cancer.